author-photo

Angela M. Krackhardt

Technische Universität München
German Cancer Research Center

81

Papers

4153

Citations

Citation Trend

Filter By

Papers (53) Sort By

Journal Conference Others

Spatial and temporal plasticity of neoantigen-specific T-cell responses bases on characteristics associated to antigen and TCR

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Encorafenib, binimetinib plus pembrolizumab triplet therapy in patients with advanced BRAFV600 mutant melanoma: safety and tolerability results from the phase I IMMU-TARGET trial.

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Triplet therapy with pembrolizumab (PEM), encorafenib (ENC) and binimetinib (BIN) in advanced, BRAF V600 mutant melanoma: Final results from the dose-finding phase I part of the IMMU-Target trial.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Identifizierung von Neoantigenen für immuntherapeutische Ansätze

2021 Onkologe
- Eva Bräunlein
- Angela M. Krackhardt
Show All
- Source
- Cite
- Save
Citations (0)
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Author Correction: Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (2)
The incidence of pulmonary immune related adverse events in serial [18F]-FDG-PET/CT is not correlated to pulmonary metastasation or intrapulmonary tumor volume but potentially to therapy response in patients treated with immunotherapy

2020 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Gene editing enables T-cell engineering to redirect antigen specificity for potent tumor rejection

2019
Show All
- Source
- Cite
- Save
Citations (19)
Change of clinical management through serial FDG-PET/CT in patients with FDG-positive adverse events under immunotherapy

2019 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)